![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: EBNA1BP2 |
Gene summary for EBNA1BP2 |
![]() |
Gene information | Species | Human | Gene symbol | EBNA1BP2 | Gene ID | 10969 |
Gene name | EBNA1 binding protein 2 | |
Gene Alias | EBP2 | |
Cytomap | 1p34.2 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | H7C2Q8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10969 | EBNA1BP2 | GSM4909281 | Human | Breast | IDC | 1.70e-04 | 3.05e-01 | 0.21 |
10969 | EBNA1BP2 | GSM4909285 | Human | Breast | IDC | 4.15e-08 | 3.63e-01 | 0.21 |
10969 | EBNA1BP2 | GSM4909286 | Human | Breast | IDC | 1.92e-04 | 1.97e-01 | 0.1081 |
10969 | EBNA1BP2 | GSM4909296 | Human | Breast | IDC | 1.22e-06 | 7.03e-02 | 0.1524 |
10969 | EBNA1BP2 | GSM4909297 | Human | Breast | IDC | 4.34e-04 | -7.39e-03 | 0.1517 |
10969 | EBNA1BP2 | GSM4909311 | Human | Breast | IDC | 3.20e-14 | -4.76e-02 | 0.1534 |
10969 | EBNA1BP2 | GSM4909312 | Human | Breast | IDC | 2.17e-09 | 1.75e-01 | 0.1552 |
10969 | EBNA1BP2 | GSM4909319 | Human | Breast | IDC | 1.46e-21 | -9.22e-02 | 0.1563 |
10969 | EBNA1BP2 | GSM4909321 | Human | Breast | IDC | 9.47e-09 | 1.03e-01 | 0.1559 |
10969 | EBNA1BP2 | brca1 | Human | Breast | Precancer | 4.70e-19 | 6.41e-01 | -0.0338 |
10969 | EBNA1BP2 | brca2 | Human | Breast | Precancer | 1.35e-09 | 3.42e-01 | -0.024 |
10969 | EBNA1BP2 | brca3 | Human | Breast | Precancer | 1.35e-02 | 2.61e-01 | -0.0263 |
10969 | EBNA1BP2 | NCCBC5 | Human | Breast | DCIS | 6.66e-14 | 4.77e-01 | 0.2046 |
10969 | EBNA1BP2 | P1 | Human | Breast | IDC | 1.89e-05 | -2.37e-01 | 0.1527 |
10969 | EBNA1BP2 | DCIS2 | Human | Breast | DCIS | 1.09e-66 | 2.97e-01 | 0.0085 |
10969 | EBNA1BP2 | LZE2T | Human | Esophagus | ESCC | 1.18e-02 | 8.84e-01 | 0.082 |
10969 | EBNA1BP2 | LZE4T | Human | Esophagus | ESCC | 5.76e-12 | 2.27e-01 | 0.0811 |
10969 | EBNA1BP2 | LZE5T | Human | Esophagus | ESCC | 3.11e-03 | 1.93e-01 | 0.0514 |
10969 | EBNA1BP2 | LZE7T | Human | Esophagus | ESCC | 7.12e-06 | 7.21e-01 | 0.0667 |
10969 | EBNA1BP2 | LZE8T | Human | Esophagus | ESCC | 2.19e-08 | 3.21e-01 | 0.067 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00226139 | Breast | Precancer | ribonucleoprotein complex biogenesis | 79/1080 | 463/18723 | 2.11e-18 | 1.03e-15 | 79 |
GO:00422549 | Breast | Precancer | ribosome biogenesis | 52/1080 | 299/18723 | 7.35e-13 | 1.51e-10 | 52 |
GO:00422739 | Breast | Precancer | ribosomal large subunit biogenesis | 22/1080 | 72/18723 | 5.03e-11 | 5.61e-09 | 22 |
GO:00063646 | Breast | Precancer | rRNA processing | 35/1080 | 225/18723 | 7.90e-08 | 4.60e-06 | 35 |
GO:00160726 | Breast | Precancer | rRNA metabolic process | 36/1080 | 236/18723 | 8.59e-08 | 4.84e-06 | 36 |
GO:00344705 | Breast | Precancer | ncRNA processing | 42/1080 | 395/18723 | 9.91e-05 | 1.83e-03 | 42 |
GO:00346604 | Breast | Precancer | ncRNA metabolic process | 45/1080 | 485/18723 | 1.15e-03 | 1.26e-02 | 45 |
GO:002261314 | Breast | IDC | ribonucleoprotein complex biogenesis | 83/1434 | 463/18723 | 2.01e-13 | 5.20e-11 | 83 |
GO:004227314 | Breast | IDC | ribosomal large subunit biogenesis | 22/1434 | 72/18723 | 1.04e-08 | 7.67e-07 | 22 |
GO:004225414 | Breast | IDC | ribosome biogenesis | 52/1434 | 299/18723 | 1.90e-08 | 1.32e-06 | 52 |
GO:000636414 | Breast | IDC | rRNA processing | 35/1434 | 225/18723 | 4.59e-05 | 1.03e-03 | 35 |
GO:001607214 | Breast | IDC | rRNA metabolic process | 36/1434 | 236/18723 | 5.48e-05 | 1.17e-03 | 36 |
GO:002261324 | Breast | DCIS | ribonucleoprotein complex biogenesis | 83/1390 | 463/18723 | 3.65e-14 | 1.09e-11 | 83 |
GO:004227324 | Breast | DCIS | ribosomal large subunit biogenesis | 22/1390 | 72/18723 | 5.88e-09 | 4.82e-07 | 22 |
GO:004225423 | Breast | DCIS | ribosome biogenesis | 52/1390 | 299/18723 | 6.73e-09 | 5.44e-07 | 52 |
GO:000636422 | Breast | DCIS | rRNA processing | 35/1390 | 225/18723 | 2.41e-05 | 5.62e-04 | 35 |
GO:001607222 | Breast | DCIS | rRNA metabolic process | 36/1390 | 236/18723 | 2.86e-05 | 6.42e-04 | 36 |
GO:003447011 | Breast | DCIS | ncRNA processing | 44/1390 | 395/18723 | 4.56e-03 | 3.49e-02 | 44 |
GO:002261327 | Esophagus | HGIN | ribonucleoprotein complex biogenesis | 158/2587 | 463/18723 | 2.61e-29 | 5.23e-26 | 158 |
GO:004225426 | Esophagus | HGIN | ribosome biogenesis | 101/2587 | 299/18723 | 8.74e-19 | 4.03e-16 | 101 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
EBNA1BP2 | SNV | Missense_Mutation | c.598C>A | p.Leu200Met | p.L200M | protein_coding | tolerated(0.07) | possibly_damaging(0.503) | TCGA-D1-A163-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | taxol | SD | ||
EBNA1BP2 | SNV | Missense_Mutation | rs535649425 | c.530N>A | p.Arg177His | p.R177H | protein_coding | deleterious(0.04) | benign(0.071) | TCGA-EY-A549-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
EBNA1BP2 | SNV | Missense_Mutation | novel | c.824N>C | p.Leu275Pro | p.L275P | protein_coding | tolerated(0.35) | benign(0.005) | TCGA-FI-A2F4-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
EBNA1BP2 | SNV | Missense_Mutation | c.826N>T | p.Ala276Ser | p.A276S | protein_coding | tolerated(0.67) | benign(0.012) | TCGA-33-4566-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
EBNA1BP2 | SNV | Missense_Mutation | novel | c.193N>C | p.Glu65Gln | p.E65Q | protein_coding | deleterious(0.03) | benign(0.438) | TCGA-63-A5MS-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
EBNA1BP2 | deletion | Frame_Shift_Del | novel | c.677delN | p.Arg226GlnfsTer25 | p.R226Qfs*25 | protein_coding | TCGA-60-2715-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | docetaxel | PD | |||
EBNA1BP2 | SNV | Missense_Mutation | novel | c.476N>A | p.Arg159Gln | p.R159Q | protein_coding | deleterious(0) | probably_damaging(0.978) | TCGA-CR-6478-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Chemotherapy | paclitaxel | SD | |
EBNA1BP2 | SNV | Missense_Mutation | rs777466628 | c.910G>T | p.Gly304Cys | p.G304C | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CV-7252-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
EBNA1BP2 | SNV | Missense_Mutation | rs181497889 | c.961N>A | p.Asp321Asn | p.D321N | protein_coding | tolerated(0.93) | benign(0.005) | TCGA-CV-7427-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
EBNA1BP2 | SNV | Missense_Mutation | novel | c.415N>A | p.Glu139Lys | p.E139K | protein_coding | tolerated(0.59) | benign(0.001) | TCGA-D6-8568-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |